<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               1 INDICATIONS AND USAGE<BR>               <BR>                  EPZICOM Tablets, in combination with other antiretroviral agents, are indicated for the treatment of HIV-1 infection.<BR>                  Additional important information on the use of EPZICOM for treatment of HIV-1 infection:<BR>                  <BR>                     EPZICOM is one of multiple products containing abacavir. Before starting EPZICOM, review medical history for prior exposure to any abacavir-containing product in order to avoid reintroduction in a patient with a history of hypersensitivity to abacavir [see Warnings and Precautions (5.1), Adverse Reactions (6)].<BR>                     <BR>                     As part of a triple-drug regimen, EPZICOM Tablets are recommended for use with antiretroviral agents from different pharmacological classes and not with other nucleoside/nucleotide reverse transcriptase inhibitors.<BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        EPZICOM, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. (1)<BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>